Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome-Reference-Cited by-同舟云学术

Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjogren's syndrome

Published:2006-02-13 Issue:8 Volume:103 Page:2770-2775
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Gottenberg J.-E.,Cagnard N.,Lucchesi C.,Letourneur F.,Mistou S.,Lazure T.,Jacques S.,Ba N.,Ittah M.,Lepajolec C.,Labetoulle M.,Ardizzone M.,Sibilia J.,Fournier C.,Chiocchia G.,Mariette X.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference55 articles.

1. Sjögren's syndrome

2. Lymphomas in Patients With Sjögren's Syndrome Are Marginal Zone B-Cell Neoplasms, Arise in Diverse Extranodal and Nodal Sites, and Are Not Associated With Viruses

3. Malignant lymphoma in primary Sj�gren's syndrome: A multicenter, retrospective, clinical study by the European concerted action on Sj�gren's syndrome

4. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response

5. Recent advances in understanding molecular mechanisms in the pathogenesis and antibody profile of Sjögren’s syndrome

Cited by 504 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathogenesis of Sjögren syndrome;Dubois' Lupus Erythematosus and Related Syndromes;2025

2. Subpopulation dynamics of T and B lymphocytes in Sjögren’s syndrome: implications for disease activity and treatment;Frontiers in Immunology;2024-09-03

3. Imbalance of dendritic cell function in pulmonary fibrosis;Cytokine;2024-09

4. Artesunate alleviates Sjögren's Syndrome by inhibiting the interferon-α signaling in plasmacytoid dendritic cells via TLR-MyD88-IRF7;Biomedicine & Pharmacotherapy;2024-08

5. Reconstruction of Sjögren's syndrome-like sialadenitis by a defined disease specific gut-reactive single TCR and an autoantibody;Clinical Immunology;2024-07